SE0000774D0 - New formulation - Google Patents

New formulation

Info

Publication number
SE0000774D0
SE0000774D0 SE0000774A SE0000774A SE0000774D0 SE 0000774 D0 SE0000774 D0 SE 0000774D0 SE 0000774 A SE0000774 A SE 0000774A SE 0000774 A SE0000774 A SE 0000774A SE 0000774 D0 SE0000774 D0 SE 0000774D0
Authority
SE
Sweden
Prior art keywords
optionally
pharmaceutical composition
composition
oil
new formulation
Prior art date
Application number
SE0000774A
Other languages
English (en)
Swedish (sv)
Inventor
Christina Holmberg
Britta Siekmann
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0000774A priority Critical patent/SE0000774D0/xx
Publication of SE0000774D0 publication Critical patent/SE0000774D0/xx
Priority to ARP010100864A priority patent/AR027554A1/es
Priority to DE60115402T priority patent/DE60115402T2/de
Priority to AU2001237875A priority patent/AU2001237875B2/en
Priority to IL15138001A priority patent/IL151380A0/xx
Priority to AT01910304T priority patent/ATE311173T1/de
Priority to HU0300539A priority patent/HU229103B1/hu
Priority to EP01910304A priority patent/EP1267831B1/fr
Priority to PL358617A priority patent/PL203549B1/pl
Priority to SK1258-2002A priority patent/SK285749B6/sk
Priority to EEP200200483A priority patent/EE200200483A/xx
Priority to RU2002122745/15A priority patent/RU2275908C2/ru
Priority to PCT/SE2001/000466 priority patent/WO2001066087A1/fr
Priority to SI200130487T priority patent/SI1267831T1/sl
Priority to ES01910304T priority patent/ES2253354T3/es
Priority to BRPI0109012-7A priority patent/BR0109012B1/pt
Priority to CZ20023006A priority patent/CZ303524B6/cs
Priority to US10/221,079 priority patent/US7736666B2/en
Priority to MXPA02008658A priority patent/MXPA02008658A/es
Priority to KR1020027011733A priority patent/KR100771318B1/ko
Priority to CA002401857A priority patent/CA2401857A1/fr
Priority to JP2001564740A priority patent/JP4656479B2/ja
Priority to CNB018062938A priority patent/CN1283229C/zh
Priority to DK01910304T priority patent/DK1267831T3/da
Priority to AU3787501A priority patent/AU3787501A/xx
Priority to MYPI20011044A priority patent/MY137749A/en
Priority to UA2002086882A priority patent/UA76098C2/uk
Priority to IS6538A priority patent/IS6538A/is
Priority to NO20024194A priority patent/NO331921B1/no
Priority to ZA200207109A priority patent/ZA200207109B/en
Priority to HK03106084A priority patent/HK1053795A1/xx
Priority to US12/768,820 priority patent/US20100266683A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0000774A 2000-03-08 2000-03-08 New formulation SE0000774D0 (sv)

Priority Applications (32)

Application Number Priority Date Filing Date Title
SE0000774A SE0000774D0 (sv) 2000-03-08 2000-03-08 New formulation
ARP010100864A AR027554A1 (es) 2000-03-08 2001-02-26 Nuevo sistema de adminstracion de farmacos autoemulsionante
AU3787501A AU3787501A (en) 2000-03-08 2001-03-06 New self emulsifying drug delivery system
ES01910304T ES2253354T3 (es) 2000-03-08 2001-03-06 Nuevo sistema de suministro de un medicamento auto-emulsionante.
US10/221,079 US7736666B2 (en) 2000-03-08 2001-03-06 Self emulsifying drug delivery system
IL15138001A IL151380A0 (en) 2000-03-08 2001-03-06 New self emulsifying drug delivery system
AT01910304T ATE311173T1 (de) 2000-03-08 2001-03-06 Neues selbstemulgierendes arzneistoffverabreichungssystem
HU0300539A HU229103B1 (en) 2000-03-08 2001-03-06 Self emulsifying drug delivery system
EP01910304A EP1267831B1 (fr) 2000-03-08 2001-03-06 Nouveau systeme de delivrance d'un medicament auto-emulsifiant
PL358617A PL203549B1 (pl) 2000-03-08 2001-03-06 Kompozycja farmaceutyczna w postaci prekoncentratu emulsji, jednostkowa posta c dawkowana i zastosowanie kompozycji farmaceutycznej
SK1258-2002A SK285749B6 (sk) 2000-03-08 2001-03-06 Farmaceutická kompozícia vo forme emulzného predkoncentrátu, jednotková dávková forma s jej obsahoma jej použitie
EEP200200483A EE200200483A (et) 2000-03-08 2001-03-06 Uus iseemulgeeruv ravimi manustamise süsteem
RU2002122745/15A RU2275908C2 (ru) 2000-03-08 2001-03-06 Новая самоэмульгирующаяся система доставки лекарств
PCT/SE2001/000466 WO2001066087A1 (fr) 2000-03-08 2001-03-06 Nouveau systeme de delivrance d'un medicament auto-emulsifiant
SI200130487T SI1267831T1 (sl) 2000-03-08 2001-03-06 Nov samoemulgirni sistem dajanja zdravil
DE60115402T DE60115402T2 (de) 2000-03-08 2001-03-06 Neues selbstemulgierendes arzneistoffverabreichungssystem
BRPI0109012-7A BR0109012B1 (pt) 2000-03-08 2001-03-06 Composição farmacêutica adequada para administração oral na forma de um pré-concentrado de emulsão, e, forma de dosagem unitária
CZ20023006A CZ303524B6 (cs) 2000-03-08 2001-03-06 Samoemulgacní systém pro podávání léciva
AU2001237875A AU2001237875B2 (en) 2000-03-08 2001-03-06 New self emulsifying drug delivery system
MXPA02008658A MXPA02008658A (es) 2000-03-08 2001-03-06 Nuevo sistema para el suministro de farmaco auto-emulsificado.
KR1020027011733A KR100771318B1 (ko) 2000-03-08 2001-03-06 신규한 자가-에멀젼화 약물 전달 시스템
CA002401857A CA2401857A1 (fr) 2000-03-08 2001-03-06 Nouveau systeme de delivrance d'un medicament auto-emulsifiant
JP2001564740A JP4656479B2 (ja) 2000-03-08 2001-03-06 新規な自己乳化薬物送達系
CNB018062938A CN1283229C (zh) 2000-03-08 2001-03-06 新的自乳化药物释放体系
DK01910304T DK1267831T3 (da) 2000-03-08 2001-03-06 Hidtil ukendt selvemulgerende system til lægemiddelindgift
MYPI20011044A MY137749A (en) 2000-03-08 2001-03-07 New self emulsifying drug delivery system
UA2002086882A UA76098C2 (en) 2000-03-08 2001-06-03 System for drug delivery with capability for self-emulsification and method for treating pain and inflammation
IS6538A IS6538A (is) 2000-03-08 2002-09-03 Nýtt sjálfgert dropakerfi fyrir lyfjagjöf
NO20024194A NO331921B1 (no) 2000-03-08 2002-09-03 Nytt selvemulgerende legemiddelavleveringssystem
ZA200207109A ZA200207109B (en) 2000-03-08 2002-09-04 New self emulsifying drug delivery system.
HK03106084A HK1053795A1 (en) 2000-03-08 2003-08-25 New self emulsifying drug delivery system
US12/768,820 US20100266683A1 (en) 2000-03-08 2010-04-28 New self emulsifying drug delivery system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000774A SE0000774D0 (sv) 2000-03-08 2000-03-08 New formulation

Publications (1)

Publication Number Publication Date
SE0000774D0 true SE0000774D0 (sv) 2000-03-08

Family

ID=20278740

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000774A SE0000774D0 (sv) 2000-03-08 2000-03-08 New formulation

Country Status (29)

Country Link
US (2) US7736666B2 (fr)
EP (1) EP1267831B1 (fr)
JP (1) JP4656479B2 (fr)
KR (1) KR100771318B1 (fr)
CN (1) CN1283229C (fr)
AR (1) AR027554A1 (fr)
AT (1) ATE311173T1 (fr)
AU (2) AU2001237875B2 (fr)
BR (1) BR0109012B1 (fr)
CA (1) CA2401857A1 (fr)
CZ (1) CZ303524B6 (fr)
DE (1) DE60115402T2 (fr)
DK (1) DK1267831T3 (fr)
EE (1) EE200200483A (fr)
ES (1) ES2253354T3 (fr)
HK (1) HK1053795A1 (fr)
HU (1) HU229103B1 (fr)
IL (1) IL151380A0 (fr)
IS (1) IS6538A (fr)
MX (1) MXPA02008658A (fr)
MY (1) MY137749A (fr)
NO (1) NO331921B1 (fr)
RU (1) RU2275908C2 (fr)
SE (1) SE0000774D0 (fr)
SI (1) SI1267831T1 (fr)
SK (1) SK285749B6 (fr)
UA (1) UA76098C2 (fr)
WO (1) WO2001066087A1 (fr)
ZA (1) ZA200207109B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
SE0102993D0 (sv) * 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
ITMI20021392A1 (it) * 2002-06-25 2003-12-29 Nicox Sa Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
US8802116B2 (en) 2003-02-27 2014-08-12 Novasel Australia Pty. Ltd. Poloxamer emulsion preparations
AU2003900887A0 (en) * 2003-02-27 2003-03-13 Novasel Australia Pty Ltd Poloxamer emulsion preparations
DE10353937A1 (de) * 2003-11-18 2005-06-30 Fresenius Medical Care Deutschland Gmbh Vorrichtung zur Übertragung einer Referenzflüssigkeit in ein Messgerät, Messgerät mit einer solchen Vorrichtung und Verfahren zur Übertragung einer Referenzflüssigkeit in ein Messgerät
GB0402679D0 (en) * 2004-02-06 2004-03-10 Novartis Ag Organic compounds
NZ550894A (en) * 2004-05-06 2011-02-25 Emisphere Tech Inc Solid dosage form of wetted heparin
WO2005112633A2 (fr) 2004-05-14 2005-12-01 Emisphere Technologies, Inc. Composes et compositions pour administration d’agents actifs
KR100654617B1 (ko) * 2004-09-23 2006-12-08 정해현 스틱이 내장된 커피믹스 팩과 커피믹스 박스
DK1906938T3 (da) 2005-07-26 2011-02-07 Nicox Sa Farmaceutisk formulering af nitrooxyderivater af NSAID'er
DK2548456T3 (en) 2008-03-20 2015-09-28 Virun Inc Emulsions including (comprising) a PEG derivative of tocopherol
CN102036661B (zh) 2008-03-20 2016-12-28 维尔恩公司 维生素衍生物及其用途
EP2488022B1 (fr) 2009-10-16 2018-01-10 Mochida Pharmaceutical Co., Ltd. Compositions
WO2011162802A1 (fr) 2010-06-21 2011-12-29 Virun, Inc. Compositions contenant des composés non polaires
US9968557B1 (en) 2011-02-09 2018-05-15 Florida A&M University Method of preparing modified multilayered microstructures with enhanced oral bioavailability
KR20240076240A (ko) * 2022-11-23 2024-05-30 (주) 바이오인프라생명과학 더블 에멀젼 구조의 초음파 감응형 약물전달체를 생성하는 방법

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
CY1398A (en) 1981-09-04 1987-12-18 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
US4554276A (en) 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4522826A (en) 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
US4766117A (en) 1984-10-11 1988-08-23 Pfizer Inc. Antiinflammatory compositions and methods
US4704278A (en) 1984-10-17 1987-11-03 American Home Products Corp (Del) Fluidized magaldrate suspension
US4676984A (en) 1985-08-14 1987-06-30 American Home Products Corp. Rehydratable antacid composition
US4757060A (en) 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
US5037815A (en) 1986-03-04 1991-08-06 Bristol-Myers Squibb Co. Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
US4965065A (en) * 1986-04-29 1990-10-23 Bristol-Myers Squibb Company Gastroprotective process and compositions
US5043358A (en) * 1986-03-04 1991-08-27 Bristol-Myers Squibb Company Gastroprotective process
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
GB8630273D0 (en) 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
EP0320550A1 (fr) 1987-12-18 1989-06-21 Bristol-Myers Company Composition NSAID contenant des bloqueurs H1, bloqueurs H2, agonistes bêta-adrénergiques ou leurs mélanges et un agent alcalinisant
SE8804629D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US5204118A (en) 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
NZ235877A (en) 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
WO1992015332A1 (fr) * 1991-03-04 1992-09-17 Warner-Lambert Company Nouvelles paires d'ions/sels de medicaments anti-inflammatoires non steroides sous differentes formes de posologie
DE4131678A1 (de) 1991-04-13 1992-10-15 Beiersdorf Ag Stabile multiple emulsionen
EP0550083B1 (fr) 1991-12-06 1999-03-24 Glaxo Group Limited Médicaments pour le traitement de conditions inflammatoires ou pour l'analgésie contenants un NSAID et du citrate de bismuth-ranitidine
AU3247593A (en) 1991-12-20 1993-07-28 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
IT1256345B (it) 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
EP0663839A4 (fr) 1992-09-29 1998-06-03 Merck & Co Inc Combinaisons d'ibuprofene-antihistaminique anti-h 2?.
IT1256450B (it) 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
DK66493D0 (da) 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
SE9302396D0 (sv) 1993-07-09 1993-07-09 Ab Astra A novel compound form
FR2710535B1 (fr) * 1993-09-30 1995-11-24 Gattefosse Ets Sa Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US6054136A (en) 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US5700947A (en) * 1993-10-06 1997-12-23 Nicox S.A. Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
EP0724441A1 (fr) 1993-10-19 1996-08-07 The Procter & Gamble Company Forme galenique picosulfate
US5514663A (en) 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US6025395A (en) * 1994-04-15 2000-02-15 Duke University Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
US5643960A (en) * 1994-04-15 1997-07-01 Duke University Method of delaying onset of alzheimer's disease symptoms
DE69512232T2 (de) * 1994-05-10 2000-02-24 Nicox Sa Nitroverbindingen und ihre zubereitungen mit entzündungsremmenden, schmertzlindernden und antithrombotischen wirkungen
CA2170647C (fr) 1994-07-08 2001-03-13 Pontus John Arvid Bergstrand Forme posologique sous forme de comprime composite (i)
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
WO1996033697A1 (fr) * 1995-04-24 1996-10-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Formulation auto-emulsionnable formant une emulsion huile dans l'eau
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
EP0760237A1 (fr) 1995-08-30 1997-03-05 Cipla Limited Microémulsions huile-dans-l'eau
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
WO1998022117A1 (fr) 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions de traitement de troubles gastro-intestinaux contenant du bismuth, des anti-inflammatoires non steroidiens ainsi qu'un ou plusieurs agents anti-microbiens et methodes correspondantes
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
SE510666C2 (sv) 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
EP0989851B1 (fr) * 1997-07-29 2002-10-02 PHARMACIA & UPJOHN COMPANY Composition pharmaceutique pour composes acides lipophiles sous forme d'une formulation autoemulsifiante
EP1017370B1 (fr) 1997-09-11 2003-10-29 Nycomed Danmark ApS Compositions contenant des unites multiples a liberation modifiee de substances medicamenteuses anti-inflammatoires non steroides (nsaid)
EP1032425A1 (fr) * 1997-10-31 2000-09-06 Monsanto Company Enrobage de comprimes a l'aide de gomme gellane
WO1999038512A1 (fr) 1998-01-30 1999-08-05 Sepracor Inc. Compositions de s-lansoprazole et procedes d'utilisation
AU742620B2 (en) 1998-01-30 2002-01-10 Sepracor, Inc. R-lansoprazole compositions and methods
WO1999056727A2 (fr) * 1998-05-07 1999-11-11 Elan Corporation, Plc Systemes d'apport de medicament de preconcentre de microemulsion et d'emulsion depourvues de solvant/cosolvant
EP0984012A3 (fr) * 1998-08-31 2001-01-10 Pfizer Products Inc. Promedicaments d'oxindole liberant du monoxyde d'azote avec propriétés analgesiques et antiinflammatoires
CN100358509C (zh) 1998-09-28 2008-01-02 沃纳-兰伯特公司 采用hpmc胶囊进行肠和结肠传递
US6485747B1 (en) * 1998-10-30 2002-11-26 Monsanto Company Coated active tablet(s)
WO2000033862A1 (fr) * 1998-12-11 2000-06-15 Pharmasolutions, Inc. Compositions auto-emulsifiantes pour medicaments peu solubles dans l'eau
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
ES2234582T3 (es) 1999-03-31 2005-07-01 PHARMACIA & UPJOHN COMPANY LLC Emulsiones farmaceuticas para inhibidores de proteasas retrovirales.
WO2000071122A1 (fr) 1999-05-20 2000-11-30 Par Pharmaceutical, Inc. Composition stabilisee a base de pyridinyl-sulfinyl-benzimidazole et procede associe
TWI243672B (en) * 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
US6126816A (en) * 1999-07-14 2000-10-03 Ruiz, Jr.; Reuben F. Wastewater treatment device
US20020102301A1 (en) * 2000-01-13 2002-08-01 Joseph Schwarz Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
US6787164B2 (en) 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
SE0000773D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US20020044962A1 (en) 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6544556B1 (en) * 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
US20020045184A1 (en) 2000-10-02 2002-04-18 Chih-Ming Chen Packaging system
FR2818905A1 (fr) * 2000-12-28 2002-07-05 Cll Pharma Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile
AR036354A1 (es) 2001-08-31 2004-09-01 Takeda Chemical Industries Ltd Preparacion solida
US7467633B2 (en) * 2005-03-10 2008-12-23 Huntsman Petrochemical Corporation Enhanced solubilization using extended chain surfactants

Also Published As

Publication number Publication date
SI1267831T1 (sl) 2006-04-30
DK1267831T3 (da) 2006-03-20
US20030077303A1 (en) 2003-04-24
EP1267831B1 (fr) 2005-11-30
ZA200207109B (en) 2003-12-04
IS6538A (is) 2002-09-03
RU2002122745A (ru) 2004-03-20
AU2001237875B2 (en) 2005-05-12
HU229103B1 (en) 2013-07-29
DE60115402T2 (de) 2006-08-03
US7736666B2 (en) 2010-06-15
CA2401857A1 (fr) 2001-09-13
PL358617A1 (en) 2004-08-09
KR20030011788A (ko) 2003-02-11
US20100266683A1 (en) 2010-10-21
AR027554A1 (es) 2003-04-02
MY137749A (en) 2009-03-31
UA76098C2 (en) 2006-07-17
EP1267831A1 (fr) 2003-01-02
BR0109012A (pt) 2003-06-03
KR100771318B1 (ko) 2007-10-29
SK12582002A3 (sk) 2003-04-01
MXPA02008658A (es) 2003-02-24
CZ20023006A3 (cs) 2003-02-12
WO2001066087A1 (fr) 2001-09-13
HK1053795A1 (en) 2003-11-07
DE60115402D1 (de) 2006-01-05
NO331921B1 (no) 2012-04-30
ATE311173T1 (de) 2005-12-15
CZ303524B6 (cs) 2012-11-14
EE200200483A (et) 2004-02-16
JP4656479B2 (ja) 2011-03-23
CN1283229C (zh) 2006-11-08
ES2253354T3 (es) 2006-06-01
NO20024194D0 (no) 2002-09-03
IL151380A0 (en) 2003-04-10
AU3787501A (en) 2001-09-17
JP2003525893A (ja) 2003-09-02
HUP0300539A2 (hu) 2003-07-28
HUP0300539A3 (en) 2003-09-29
CN1416336A (zh) 2003-05-07
RU2275908C2 (ru) 2006-05-10
SK285749B6 (sk) 2007-07-06
NO20024194L (no) 2002-09-03
BR0109012B1 (pt) 2014-08-26

Similar Documents

Publication Publication Date Title
SE0000774D0 (sv) New formulation
SE0000773D0 (sv) New formulation
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
BR0213358A (pt) Uso de flibanserina
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
PT989851E (pt) Formulacao auto-emulsionante para compostos lipofilicos acidicos
MXPA05013278A (es) Composiciones farmaceuticas que comprenden compuestos activos de vitamina d.
SE0102993D0 (sv) New self emulsifying drug delivery system
FR2849992B1 (fr) Composition pour une administration par voie orale contenant des capsaicinoides
AR045094A1 (es) Formulaciones liofilizadas de cci-779
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
HK1074382A1 (en) A cosmetic or pharmaceutical formulation comprising a silicone compound and water emulsion
AR046402A1 (es) Combinacion de principio activo que comprende un compuesto 2,5-dihidrobencenosulfonico y un modulador de los canales de potasio
DE60101370D1 (de) Pharmazeutische zusammensetzungen, die terbinafin enthalten
PE20020423A1 (es) Composicion farmaceutica con actividad de agua especifica
BR0108732A (pt) Composição farmacêutica para a prevenção e tratamento da progressão da fibrose e cirrose hepática, seu uso e método para a prevenção e tratamento da fibrose e cirrose hepática
EA200600009A2 (ru) Фармацевтические композиции, содержащие активные соединения витамина d
AR012019A1 (es) Compuesto de criptoficina y su uso para preparar un medicamento
KR970005289A (ko) 디프사쿠스 사포닌 C(Dipsacus saponin C)를 유효성분으로 함유하는 비마약성 중추성 진통제
TH100976B (th) ระบบนำส่งยาแบบอีมัลชิฟายตัวเองชนิดใหม่